These experiments also revealed that the inhibition of SORBS1 in cancer cells malignant transformation is mediated by repressed JNK/c-Jun activation, and that the suppression of SORBS1 in drug resistance is mediated by increased p53 level. This evidence concerns the gene TP53 and cancer.